Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated bianually. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take Newsletter

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

Read Now

News and Insights

Showing items 1 to3 of 6

Categories
Tags
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Results 1

Date
Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill
Insight
Our Take Newsletter
January 5, 2026

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

Learn More
January 5, 2026
health
fda
Novo Nordisk
Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products
Insight
Our Take Newsletter
December 22, 2025

Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products

Learn More
December 22, 2025
drugmaker
drug
american medical association
Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations
Insight
Our Take Newsletter
January 14, 2026

Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

Learn More
January 14, 2026
ourtake
retatrutide
Our Take: Eli Lilly achieves market value of $1 trillion
Insight
Our Take Newsletter
December 8, 2025

Our Take: Eli Lilly achieves market value of $1 trillion

Learn More
December 8, 2025
Eli Lilly
Novo Nordisk
Our Take: Abbott to boost its diagnostics portfolio with $21 billion acquisition of Exact Sciences
Insight
Our Take Newsletter
November 24, 2025

Our Take: Abbott to boost its diagnostics portfolio with $21 billion acquisition of Exact Sciences

Learn More
November 24, 2025
Cigna
2025
ourtake
abbott
Our Take: CMS launches payment model to lower Medicaid drug spending
Insight
Our Take Newsletter
November 17, 2025

Our Take: CMS launches payment model to lower Medicaid drug spending

Learn More
November 17, 2025
UnitedHealthcare
CMS
medicaid
drug
2025
Our Take: Pfizer wins bidding war to acquire Metsera
Insight
Our Take Newsletter
November 10, 2025

Our Take: Pfizer wins bidding war to acquire Metsera

Learn More
November 10, 2025
Pfizer
2025
ourtake
Our Take: PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs
Insight
Our Take Newsletter
November 3, 2025

Our Take: PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs

Learn More
November 3, 2025
PBM
2025
ourtake
prescription
CVS
Our Take: An uptick in health system collaborations and affiliations
Insight
Our Take Newsletter
October 27, 2025

Our Take: An uptick in health system collaborations and affiliations

Learn More
October 27, 2025
2025
health system
collaboration
Our Take: Amazon to offer pharmacy kiosks at One Medical clinics
Insight
Our Take Newsletter
October 13, 2025

Our Take: Amazon to offer pharmacy kiosks at One Medical clinics

Learn More
October 13, 2025
amazon
rx
2025
Our Take: New California laws take aim at PBMs and more
Insight
Our Take Newsletter
October 20, 2025

Our Take: New California laws take aim at PBMs and more

Learn More
October 20, 2025
PBM
virtual primary care
ourtake
2025
Our Take: Feature: Notable recent transactions among Big Pharma and life sciences companies
Insight
Our Take Newsletter
September 22, 2025

Our Take: Feature: Notable recent transactions among Big Pharma and life sciences companies

Learn More
September 22, 2025
big pharma
ourtake
Gilead Sciences
Stay Aware. Stay Informed.

Want to strengthen your account planning?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.